Online ISSN: 1945-4589
Learn about our FREE Post-Publication Promotion Services
Editorial Volume 9, Issue 5 pp 1357—1358

Repurposing ARBs as treatments for breast cancer

Amee J. George1,2,3, , Andrew Allen4, , Ashwini L. Chand5,6, ,

  • 1 The ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia
  • 2 Department of Pathology, University of Melbourne, VIC, Australia
  • 3 School of Biomedical Sciences, University of Queensland, QLD, Australia
  • 4 Department of Physiology, University of Melbourne, VIC, Australia
  • 5 Cancer and Inflammation Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, VIC, Australia
  • 6 School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia

Received: May 25, 2017       Published: May 31, 2017      

https://doi.org/10.18632/aging.101249
How to Cite

Copyright: © 2017 George et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Download PDF
Corresponding Author

Ashwini L. Chand
ashwini.chand@onjcri.org.au

Keywords
angiotensin receptor blockers breast cancer cardiovascular disease mammary tumour models